Flulaval

Generic name:influenza virus vaccine
Dosage form: injection, suspension
Drug class:Viral vaccines

Medically reviewed by Drugs.com. Last updated on Jun 21, 2021.

Indications and Usage for Flulaval

Flulaval® is indicated for active immunization of adults (18 years of age and older) against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

This indication is based on immune response elicited by Flulaval, and there have been no controlled trials demonstrating a decrease in influenza disease after vaccination with Flulaval [see Clinical Studies (14)].

Flulaval Dosage and Administration

Preparation for Administration

Shake the multi-dose vial vigorously each time before withdrawing a dose of vaccine. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If either of these conditions exists, the vaccine should not be administered.

Between uses, return the multi-dose vial to the recommended storage conditions, between 2º and 8ºC (36º and 46ºF). Do not freeze. Discard if the vaccine has been frozen. Once entered, a multi-dose vial, and any residual contents, should be discarded after 28 days.

It is recommended that small syringes (0.5-mL or 1-mL) be used to minimize any product loss.

Recommended Dose and Schedule

Flulaval should be administered as a single 0.5-mL injection by the intramuscular route preferably in the region of the deltoid muscle of the upper arm.

The vaccine should not be injected in the gluteal area or areas where there may be a major nerve trunk. A needle length of ≥1 inch is preferred because needles <1 inch might be of insufficient length to penetrate muscle tissue in certain adults.